Otsuka Holdings Co., Ltd.
4578
Classement en actions
#578
Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals,... Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. It develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, autoimmune space digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipment, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, quasi-drugs, household products, and packaging materials and electronic parts. In addition, it offers IT solutions; adhesive tapes; flaky titanate and compounds; infusion and clinical nutrition products; hydrazine; plant-based food products; reinsurance underwriting services; wine; stable isotopes; food supplements; software and services for management of mental healthcare systems; anticancer drugs; terracess; bio-pesticides; dietetic food products; spring and mineral water; and polyolefin foams. Further, it engages in the warehousing and transport, medical device operational management, shared service, environmental health management, and venture capital and incubation businesses; rental of medical devices and related products; purchase and sale of agricultural products; import and export trading business; tuberculosis research and development activities; rental of space and office businesses; manufacturing and development of xenotransplantation products; and processing and marketing of functional films, as well as planning, design, production, and construction of ceramic boards and arts, ceramic walls, reliefs, terracotta, ceramic OT and portraits, and ceramic sign boards; and operation of travel agency, and Hotel Ridge and California Table. The company was founded in 1921 and is headquartered in Chiyoda, Japan.
Prix de l'action
$78.91
Capitalisation boursière
$41.43B
Changement (1 jour)
-0.28%
Changement (1 an)
45.76%
Pays
JP
Échange Otsuka Holdings Co., Ltd. (4578)
Catégorie
Healthcare
Ratio P/E pour Otsuka Holdings Co., Ltd. (4578)
Ratio P/E au October 2026 TTM : 16.13
Selon les derniers rapports financiers et le cours de l'action de Otsuka Holdings Co., Ltd., le ratio P/E actuel (TTM) est de 16.13. À la fin de l’année 2024, le P/E de l’entreprise était de 13.57.
Historique du ratio P/E pour Otsuka Holdings Co., Ltd. de 2009 à 2026
Ratio P/E à la fin de chaque année
| Année | Ratio P/E | Changez |
|---|---|---|
| 2026 (TTM) | 16.13 | 24.57% |
| 2025 | 12.95 | -4.55% |
| 2024 | 13.57 | -42.50% |
| 2023 | 23.60 | 35.30% |
| 2022 | 17.44 | -3.22% |
| 2021 | 18.02 | 11.43% |
| 2020 | 16.17 | -22.31% |
| 2019 | 20.82 | -29.46% |
| 2018 | 29.51 | 23.83% |
| 2017 | 23.83 | -20.06% |
| 2016 | 29.81 | 7.17% |
| 2015 | 27.82 | 114.73% |
| 2014 | 12.96 | -9.44% |
| 2013 | 14.31 | -3.53% |
| 2012 | 14.83 | 16.77% |
| 2011 | 12.70 | -14.81% |
| 2010 | 14.91 | -31.17% |
| 2009 | 21.66 | 0.00% |
Ratio P/E pour des entreprises similaires ou concurrentes
| Entreprise | P/E Ratio | Différence du P/E Ratio | Pays |
|---|---|---|---|
| 43.73 | 171.07% |
US
|
|
| 39.77 | 146.52% |
US
|
|
| 80.21 | 397.23% |
US
|
|
| 121.17 | 651.09% |
US
|
|
| 25.53 | 58.24% |
CH
|
Comment lire un P/E ratio ?
Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.
Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.
Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.